ReviewOsteoarthritis imaging2026
20 Years of the International Workshop on Osteoarthritis imaging (IWOAI): From a Small Pre-Alpine Village to a Global Community.
Review in Osteoarthritis imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe International Workshop on Osteoarthritis Imaging (IWOAI) was founded in 2007 to create a focused scientific forum dedicated to imaging (biomarkers) in osteoarthritis. In contrast to large international congresses, the workshop was conceived as a small and interactive meeting encouraging open discussion and interdisciplinary exchange among researchers from academia and industry. PERSPECTIVE: Since its first meeting in 2007 in the remote pre-Alpine village of Ainring, IWOAI has evolved into an annual global series of workshops bringing together international experts from many different disciplines. Despite its worldwide expansion, the workshop has remained limited in size, with up to 150 participants (South Carolina in 2012) but often smaller. The retreat-like format has allowed ample time for discussion and personal interaction. It has fostered a collaborative environment in which methodological challenges, emerging imaging technologies, publicly accessible cohorts and image repositories (e.g. the Osteoarthritis Initiative), and regulatory aspects of imaging biomarkers are discussed in depth. Informal interactions during social events and post-conference excursions have strengthened professional networks, collaborations, and personal friendships across disciplines and institutions. Over time, the workshop community also contributed to strengthening the field institutionally by establishing the International Society for Osteoarthritis Imaging (ISOAI) in 2019. OUTLOOK: As imaging technologies, AI-based automated image analysis, and data science continue to advance, imaging biomarkers are expected to play an increasingly important role in osteoarthritis clinical research and therapeutic development. Continued collaboration among academic researchers, clinicians, industry scientists and regulators will remain essential for translating imaging advances into meaningful clinical applications, trials, and ultimately disease-modifying therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.